1-7 of 7
Nikesh Shah
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Sociodemographic determinants of survival in acute lymphoblastic leukemia: A 20-year SEER-based analysis

Free
Jahnavi Chaudhari, Adit Patel, Hetul Chaudhari, Himil Mahadevia, Nikesh Shah
Journal: Blood
Blood (2025) 146 (Supplement 1): 5105.
https://doi.org/10.1182/blood-2025-5105
Published: 2025
Journal Articles

Implementation of an innovative hospital at home program for patients with hematalogic malignancies

Free
Nikesh Shah, Joanna Barris, Colleen Mcintosh, Peter Chang, Corinne Shamehdi, Daniel Kerr, Megan Melody, Ivan Borrello, Eduardo Sotomayor, David Swoboda
Journal: Blood
Blood (2025) 146 (Supplement 1): 520.
https://doi.org/10.1182/blood-2025-520
Published: 2025
Journal Articles

Use and outcomes following blinatumomab rechallenge in adolescents and young adults (AYA) and adults with B-cell acute lymphoblastic leukemia (B-ALL)

Free
Michaela Liedtke, Nikesh Shah, Jessica Leonard, Anthony Proli, Yazan Barqawi, Hui-Han Chen, Alan Yong, Vikram Shetty, Elias Jabbour, Mark Geyer
Journal: Blood
Blood (2025) 146 (Supplement 1): 1555.
https://doi.org/10.1182/blood-2025-1555
Published: 2025
Journal Articles

Real world comparison of commercial CAR T-cell constructs for the treatment of LBCL

Free
Megan Melody, Alan Kerr, Megan Herr, Adit Dharia, Nicole Altomare, Natalie Grover, Colin Thomas, Omar Elghawy, Yun Kyoung Tiger, Alexandra Noveihed, Ari Pelcovits, Thomas Ollila, Matthew Cortese, James Davis, Adam Kidwell, Tamara Moyo, Lindsey Fitzgerald, Jonathon Cohen, Nikesh Shah, David Swoboda, Vaishalee Kenkre, Geoffrey Shouse, Daniel Antonio, Deborah Stephens, Nirav Shah, Jonathan Moreira, Shuo Ma, Jane Winter, Leo Gordon, Narendranath Epperla, Reem Karmali, Brian Hess
Journal: Blood
Blood (2025) 146 (Supplement 1): 781.
https://doi.org/10.1182/blood-2025-781
Published: 2025
Journal Articles

Outcomes of patients with Relapsed/Refractory aggressive B-cell lymphoma receiving bispecific antibody therapy as monotherapy or in combination with targeted therapy

Free
Timothy Oh, Ari Pelcovits, Natalie Grover, Colin Thomas, Yun Kyoung Tiger, Matthew Cortese, James Davis, Adam Kidwell, Tamara Moyo, Lindsey Fitzgerald, Jonathon Cohen, Megan Melody, Nikesh Shah, Vaishalee Kenkre, Brian Hess, Thomas Ollila, Megan Herr, Geoffrey Shouse, Salmaan Mubeen, Omar Elghawy, Daniel Antonio, Daniel Kerr, Calvin Lee, Jonathan Moreira, Shuo Ma, Jane Winter, Nirav Shah, Leo Gordon, Narendranath Epperla, Deborah Stephens, Reem Karmali
Journal: Blood
Blood (2025) 146 (Supplement 1): 4551.
https://doi.org/10.1182/blood-2025-4551
Published: 2025
Journal Articles

Characterizing the US Patient Population Receiving Rituximab with Gemcitabine and Oxaliplatin (R-GemOx) for Relapsed or Refractory Diffuse Large B-Cell Lymphoma Using Real-World Data

Free
Lihua E. Budde, Adam J. Olszewski, Bei Hu, Nikesh Shah, Connie Lee Batlevi, Shen Yin, Iris To, Michael C. Wei, Martine Kallemeijn, Victor Orellana-Noia, Lisa Musick, Natasha Shamas, Navdeep Pal, Ashwini Shewade, Jason R. Westin
Journal: Blood
Blood (2024) 144 (Supplement 1): 2373.
https://doi.org/10.1182/blood-2024-194340
Published: 2024
Journal Articles

Use of Lenalidomide Plus Rituximab in TP53-Mutated Mantle Cell Lymphoma (MCL) Outside of Clinic Trial: The Moffitt Experience

Free
Nikesh Shah, MD, Franco Castillo-Tokumori, MD, Julio C. Chavez, MD, Leidy Isenalumhe, MD, Hayder Saeed, MD, Celeste Bello, MD, Lubomir Sokol, MD PhD, Javier Pinilla Ibarz, MD PhD, Bijal Shah, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3991.
https://doi.org/10.1182/blood-2019-127291
Published: 2019